| Net Cash Provided by (Used in) Operating Activities |
$1,429,000,000 |
USD |
75% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$2,067,000,000 |
USD |
106% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,695,000,000 |
USD |
54% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
140,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
85,310,598 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,825,000,000 |
USD |
-38% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$4,168,000,000 |
USD |
25% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$61,000,000 |
USD |
24% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$726,000,000 |
USD |
7.1% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$3,182,000,000 |
USD |
2.3% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$3,015,000,000 |
USD |
56% |
Q4 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$350,000,000 |
USD |
7.7% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$829,000,000 |
USD |
-2% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$37,000,000 |
USD |
12% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$2,456,000,000 |
USD |
1% |
Q4 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$7,000,000 |
USD |
17% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$366,000,000 |
USD |
20% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |